Fenglei Li

1.4k total citations
49 papers, 1.0k citations indexed

About

Fenglei Li is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Fenglei Li has authored 49 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Surgery, 16 papers in Pulmonary and Respiratory Medicine and 9 papers in Oncology. Recurrent topics in Fenglei Li's work include Esophageal Cancer Research and Treatment (20 papers), Esophageal and GI Pathology (13 papers) and Gastric Cancer Management and Outcomes (7 papers). Fenglei Li is often cited by papers focused on Esophageal Cancer Research and Treatment (20 papers), Esophageal and GI Pathology (13 papers) and Gastric Cancer Management and Outcomes (7 papers). Fenglei Li collaborates with scholars based in China, Ethiopia and United Kingdom. Fenglei Li's co-authors include Zhigang Tian, Haiming Wei, Rui Sun, Yongyan Chen, Chuanhai Guo, Zhisong He, Yaqi Pan, Hong Cai, Mengfei Liu and Wenwei Yin and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Fenglei Li

46 papers receiving 1000 citations

Peers

Fenglei Li
Tomer Adar Israel
Ida Hilmi Malaysia
Kunihiko Murase Japan
Yafei Zhang China
Fabrizio Bossa Italy
Nasir Mahmud Ireland
Bertrand Roquelaure France
Christine Rungoe Denmark
Ewert Schulte‐Frohlinde Germany
Polychronis Pavlidis United Kingdom
Tomer Adar Israel
Fenglei Li
Citations per year, relative to Fenglei Li Fenglei Li (= 1×) peers Tomer Adar

Countries citing papers authored by Fenglei Li

Since Specialization
Citations

This map shows the geographic impact of Fenglei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fenglei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fenglei Li more than expected).

Fields of papers citing papers by Fenglei Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fenglei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fenglei Li. The network helps show where Fenglei Li may publish in the future.

Co-authorship network of co-authors of Fenglei Li

This figure shows the co-authorship network connecting the top 25 collaborators of Fenglei Li. A scholar is included among the top collaborators of Fenglei Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fenglei Li. Fenglei Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Fang, et al.. (2024). Negative causal exploration of systemic sclerosis: a Mendelian randomization analysis. Scientific Reports. 14(1). 5200–5200. 4 indexed citations
2.
Liu, Mengfei, Wenlei Yang, Chuanhai Guo, et al.. (2024). Effectiveness of Endoscopic Screening on Esophageal Cancer Incidence and Mortality: A 9-Year Report of the Endoscopic Screening for Esophageal Cancer in China (ESECC) Randomized Trial. Journal of Clinical Oncology. 42(14). 1655–1664. 16 indexed citations
3.
Li, Fenglei, Sobhan Roy, Keith G. Gould, et al.. (2024). Ligand-induced segregation from large cell-surface phosphatases is a critical step in γδ TCR triggering. Cell Reports. 43(9). 114761–114761. 5 indexed citations
4.
Liu, Mengfei, Ren Zhou, Chuanhai Guo, et al.. (2024). Persistence of Lugol-unstaining Is Associated With an Increased Risk of Progression to Malignancy in the Esophagus. Clinical Gastroenterology and Hepatology. 23(8). 1337–1345.e12. 1 indexed citations
5.
Liu, Mengfei, Chuanhai Guo, Haijun Yang, et al.. (2023). How should extra‐large Lugol‐unstained lesions of the esophagus be treated? Results from a population‐based cohort study. Cancer Medicine. 12(19). 20129–20139. 2 indexed citations
6.
Liu, Mengfei, Chuanhai Guo, Ruiping Xu, et al.. (2022). Cost-effectiveness of precision screening for esophageal cancer based on individualized risk stratification in China: Real-world evidence from the ESECC trial. Frontiers in Oncology. 12. 1002693–1002693. 2 indexed citations
7.
Wang, Minmin, Mengfei Liu, Chuanhai Guo, et al.. (2021). Association of early-life undernutrition and risk of dyslipidemia in adulthood: a population-based cohort study. BMC Public Health. 21(1). 2129–2129. 4 indexed citations
8.
Wang, Minmin, Mengfei Liu, Fenglei Li, et al.. (2020). Gender heterogeneity in dyslipidemia prevalence, trends with age and associated factors in middle age rural Chinese. Lipids in Health and Disease. 19(1). 135–135. 21 indexed citations
9.
Liu, Fangfang, Mengfei Liu, Ying Liu, et al.. (2020). Oral microbiome and risk of malignant esophageal lesions in a high-risk area of China: A nested case-control study. Chinese Journal of Cancer Research. 32(6). 742–754. 17 indexed citations
10.
Li, Fenglei, Yongyan Chen, Haiming Wei, et al.. (2019). CD4+ T Cells Play a Critical Role in Microbiota-Maintained Anti-HBV Immunity in a Mouse Model. Frontiers in Immunology. 10. 927–927. 16 indexed citations
11.
Zong, Lu, Hui Peng, Cheng Sun, et al.. (2019). Breakdown of adaptive immunotolerance induces hepatocellular carcinoma in HBsAg-tg mice. Nature Communications. 10(1). 221–221. 66 indexed citations
12.
Xu, Ruiping, Fenglei Li, Chuanhai Guo, et al.. (2019). Identification of cancer patients using claims data from health insurance systems: A real-world comparative study. Chinese Journal of Cancer Research. 31(4). 699–706. 15 indexed citations
13.
Liu, Mengfei, Zhen Liu, Fangfang Liu, et al.. (2019). Absence of Iodine Staining Associates With Progression of Esophageal Lesions in a Prospective Endoscopic Surveillance Study in China. Clinical Gastroenterology and Hepatology. 18(7). 1626–1635.e7. 18 indexed citations
14.
Li, Xiang, Chuanhai Guo, Ruiping Xu, et al.. (2019). Estimation of Cost for Endoscopic Screening for Esophageal Cancer in a High-Risk Population in Rural China: Results from a Population-Level Randomized Controlled Trial. PharmacoEconomics. 37(6). 819–827. 14 indexed citations
15.
16.
Li, Fenglei, Xiaolei Hao, Yongyan Chen, et al.. (2017). The microbiota maintain homeostasis of liver-resident γδT-17 cells in a lipid antigen/CD1d-dependent manner. Nature Communications. 8(1). 13839–13839. 143 indexed citations
17.
Li, Fenglei & Zhigang Tian. (2013). The liver works as a school to educate regulatory immune cells. Cellular and Molecular Immunology. 10(4). 292–302. 75 indexed citations
18.
Zhao, Dongxing & Fenglei Li. (2012). Rehabilitation of modified exercise prescription for patients with stable chronic obstructive pulmonary disease. Chinese Journal of Asthma. 32(9). 678–682. 3 indexed citations
19.
Li, Fenglei, Hairong Wei, Haiming Wei, et al.. (2012). Blocking the Natural Killer Cell Inhibitory Receptor NKG2A Increases Activity of Human Natural Killer Cells and Clears Hepatitis B Virus Infection in Mice. Gastroenterology. 144(2). 392–401. 142 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tomer Adar Breakdown of academic impact, for papers by Ida Hilmi Breakdown of academic impact, for papers by Kunihiko Murase Breakdown of academic impact, for papers by Yafei Zhang Breakdown of academic impact, for papers by Fabrizio Bossa Breakdown of academic impact, for papers by Nasir Mahmud Breakdown of academic impact, for papers by Bertrand Roquelaure Breakdown of academic impact, for papers by Christine Rungoe Breakdown of academic impact, for papers by Ewert Schulte‐Frohlinde Breakdown of academic impact, for papers by Polychronis Pavlidis
Rankless by CCL
2026